Objective: To assess the incidence of periventricular/intraventricular hemorrhage (PIVH) in very low birth rate neonates.
Diagnoses were established by means of bedside ultrasonography using an Aloka 620 ® scanner and a 5 mHz probe. The PIVH screening protocol followed at our facility consists of serial ultrasound assessment of all neonates with a birth weight < 1,500 g at 72 hours (or sooner), 1 week, and 28 days of age (or at discharge), with a maximum acceptable deviation of 24 hours.
Data were recorded in patient charts and later entered into the SPSS 7.5 for Windows software application. Sample size was not calculated, as this was a study of incidence and all children deemed eligible during the study period were included. The chi-square or Cochran-Armitage tests for trend were used to ascertain whether the incidence of PIVH followed an upward or downward trend over the study period. Annual incidence was analyzed using a simple linear regression model, with a logarithmic trend line as the output. The level of significance was set at p < 0.05 with a 95% confidence interval. This study was approved by the Research Ethics
Committee of the healthcare facility at which it was conducted.
Results
A total of 45,652 infants were born during the study period, 1,777 of whom with a weight of less than 1,500 g (3.9%). Of these, 17.5% were excluded from the sample due to early death, 0.9% due to cerebral malformations, and 3.8% who did not undergo ultrasound assessment, for a final sample of 1,341 neonates.
Across the entire study period, 289 very low birth weight infants developed PIVH (20.9%). Analysis of the annual distribution of cases revealed a marked, statistically significant decline in the incidence of this condition, from 50.9% in 1991 to 11.9% in 2005 (p < 0.0001). The lowest PIVH rate was measured in 2001 (11.6%). Annual incidence data and a trendline for the incidence of PIVH over the 15-year study period are shown in Figure 1 .
Analysis of the distribution of PIVH by weight range showed the incidence was highest in neonates with a birth weight < 750 g (32.6%), and lowest (11.6%) in those with a birth weight of 1,251-1,499 g. Table 1 . The rate of sampling loss throughout the 15-year study period was quite low (3.8%), which may be explained by the fact that all ultrasound examinations were performed at the bedside, without interfering with the dynamics of neonatal care. Adequate training of two service neonatologists enabled systematic adherence to the study protocol without depending on other providers. It should also be noted that transfontanellar ultrasonography is an excellent method for diagnosis of PIVH with sensitivity and specificity comparable to those of magnetic resonance imaging for detection of cerebral hemorrhage in preterm neonates. 12 The aforementioned loss rate does not appear to have skewed the study results, as it was relatively homogeneous over time. Furthermore, the subjects lost to follow-up were generally in higher birth weight ranges and at lower risk of PIVH; their ultimate influence on incidence data may be considered negligible.
Our choice of birth weight as a parameter for stratification is justified by the unreliability of gestational age assessment.
Theoretically, gestational age would be the most relevant variable, as the most intense proliferation of the germinal matrix (the site of PIVH) occurs between weeks 26 and 32 of development. This period is followed by involution of the matrix, which would decrease the risk of bleeding.
However, assessment of gestational age in our setting is based on somewhat unreliable methods: menstrual history, fetal ultrasonography, and clinical examination. In light of this universal issue, birth weight is the variable most often used to define groups at high risk of PIVH.
Over the study period, the incidence of PIVH in very low birth weight (< 1,500 g) neonates declined significantly, shows that the decline in cases was most pronounced in lower-weight infants; in fact, PIVH tended to disappear in the > 1,250 g group. This downward trend has been observed worldwide since the 1980s. 1, 9, 13 In 1998, Sheth 14 described a decline in the incidence of PIVH (from 29.7% to 14.4%) over a 10-year period, in a sample of 867 very low birth weight infants born between 1986 and 1995.
Analysis of potential risk factors associated with this decline in the incidence of PÌVH revealed that some factors usually associated with this disease, such as maternal age, prenatal care, and vaginal delivery, were not associated with significant between-group differences over the 15-year study period. On the other hand, we did detect an increase in the proportion of very low birth weight infants and a decrease in the number of male infants.
Therefore, this decline in PIVH incidence rates may be attributed to an overall improvement in neonatal care, although some practices are not directly related to development of this condition.
Over the 15-year study period, antenatal corticosteroid use became considerably more widespread at our facility. This practice has been reported in the literature as a protective factor against development of PIVH, both indirectly as an inducer of lung maturity and hemodynamic stability and due to its direct action on maturation of blood vessels in the germinal matrix. 15, 16 A Brazilian study found that antenatal corticosteroids significantly reduced the incidence of severe PIVH in preterm neonates. 17 However, in Brazil, this therapy has yet to be employed in a widespread, standardized manner. In data compiled by the Brazilian Neonatal Research Network (Dados da Rede Brasileira de Pesquisas Neonatais) from eight university centers, the rate of antenatal corticosteroid administration ranged from 12.5% to 87.5%. 18 Administration of exogenous surfactant for treatment of respiratory distress syndrome was also implemented and widely used throughout the study period. As respiratory failure and mechanical ventilation are associated with PIVH, we expected surfactant use would reduce its incidence.
Nevertheless, there is no clear evidence of any such protective effect in most studies. This holds particularly true for infants born at a gestational age of < 27 weeks, and is most likely related to the extreme pulmonary immaturity of this age group and to the multifactorial nature of PIVH.
Prophylactic administration of surfactant has also not proved superior to rescue use of surfactant in prevention of PIVH and its severe manifestations, nor has the type of surfactant shown any association with protection against PIVH. As surfactant has received formal regulatory approval for the treatment of neonatal respiratory distress syndrome, placebo-controlled trials are unlikely to be conducted in future. 19, 20 Remarkably, throughout the study period, some factors that are known to be associated with PIVH -such as
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widespread use of mechanical ventilation, sepsis, patent ductus arteriosus, and hemodynamic disorders -remained present. As PIVH rates declined significantly over time, we sought to determine which changes in the service where the study was conducted could have justified this finding.
Over the 15 years of our investigation, the neonatology unit in which it was carried out underwent several major changes, both in terms of infrastructure and technological advances and in implementation of patient-centered care.
The incidence of PIVH declined most markedly from 1996
onward. This period coincided with a renovation of the unit after a turbulent time of high occupancy rates and inadequate physical infrastructure, supplies, and personnel.
Substantial investments were made toward the acquisition of new equipment, physicians and nurses were hired, and a program designed to regionalize neonatal care was implemented. In a study of 17 Canadian NICUs, Synnes et al. found that the incidence of severe PIVH was associated not only with the characteristics of the infants themselves, but also -and significantly so -with the structural aspects of how each unit was organized, including personnel, staffto-bed ratios, and availability of specialty care. 21 Handling and management of neonates, and particularly of extremely low and very low birth weight infants, has also undergone major changes. Since 1996, neonatal resuscitation in the delivery room has followed Brazilian pressure) and changes in heart rate and blood pressure. 22 Furthermore, patient-ventilator asynchrony (a lack of coordination between the spontaneous respiratory efforts of the neonate and those delivered by the ventilator) also leads to significant changes in cerebral hemodynamics.
Likewise, the ventilation process has changed over time to become less aggressive and tolerant of a broader range of pCO 2 levels than traditionally accepted, thus avoiding extreme hypo-and hypercapnia alike, which induce acute reductions in cerebral blood flow and are thus damaging to the developing brain of preterm infants. 23 Routine tracheal aspiration has been ascribed a significant role in the pathogenesis of PIVH. It has been well documented that changes in blood pressure, cerebral blood flow, and intracranial pressure occur during this procedure. Although there is no high-level evidence to support this assertion, there is consensus that tracheal aspiration should be performed selectively and on a case-by-case basis. 22 The hemodynamic management of newborn infants has also undergone major In this study, the incidence of all grades of PIVH declined, with particularly marked decreases in the incidence of Grade I and II disease. Furthermore, the lowest the birth weight of the infant, the higher the rate of severe hemorrhage; therefore, the less severe forms of PIVH are predominant in children with a higher birth weight.
The distribution of PIVH grades by birth weight reflects an overall decrease in the neonatal mortality rate of increasingly younger children (those at the highest risk of developing PIVH) due to technological advances. 30 Reduction of PIVH (particularly its high-grade forms)
in surviving neonates may be beneficial, as these more severe forms of the disease carry an unfavorable prognosis.
Neurological sequelae are associated with motor, cognitive, and global impairment due to demyelination and a reduction in the number of axons, dendrites, neurons, and synapses. 31 Although evidence of a certain degree of plasticity in long-term neurodevelopmental processes has led to a guardedly optimistic prognosis for neonates with high-grade PIVH, severe sonographic changes and altered neurologic examination findings suggest more serious brain injury and, therefore, a poorer potential for recovery. 32 Several studies have provided ample evidence that severe (Grade III/IV) PIVH is associated with impaired neurologic development. Ment et al. 31 reported that, at 12 years of age, 60% of surviving neonates with Grade III/IV PIVH and a birth weight of 600-1,250 g had cerebral palsy, 70% had mental retardation, and 92% still required rehabilitation. No treatment cost estimates are available for Brazil, but a reduction in the number of patients with severe PIVH, as occurred in our sample, is certain to provide substantial cost savings -particularly in developing nations.
In short, the present study detected a downward trend in the incidence of PIVH over time, across all grades of severity and all birth weight ranges. These findings suggest that major changes occurred in the neonatal intensive care unit where the study was conducted, namely, the implementation of practices meant to minimize the risk of this condition. We believe the results of this investigation will provide positive feedback to the multidisciplinary team of the unit with regard to their neonatal care practices and provide these children, their relatives, and society as a whole with the possibility of more dignified living and greater quality of life.
